231 related articles for article (PubMed ID: 33479809)
21. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
Zhang F; Deng Y; Wang D; Wang S
Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
[TBL] [Abstract][Full Text] [Related]
23. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
Liu Z; Yu L; Lai J; Zhang R
Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
[TBL] [Abstract][Full Text] [Related]
24. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
Tang J; Wan Q; Lu J
BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
[TBL] [Abstract][Full Text] [Related]
25. Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma.
Chen Y; Chen L; Wang J; Tan J; Wang S
Dis Markers; 2021; 2021():2401617. PubMed ID: 34426753
[TBL] [Abstract][Full Text] [Related]
26. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
Xia F; Yu Z; Deng A; Gao G
Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
[TBL] [Abstract][Full Text] [Related]
27. A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.
Tang Z; Cai K
Anal Cell Pathol (Amst); 2021; 2021():6693219. PubMed ID: 34434692
[TBL] [Abstract][Full Text] [Related]
28. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
[TBL] [Abstract][Full Text] [Related]
29. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
[TBL] [Abstract][Full Text] [Related]
30. Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas.
Wang Z; Zhu L; Li K; Sun Y; Giamas G; Stebbing J; Peng L; Yu Z
Cancer Gene Ther; 2022 Oct; 29(10):1418-1428. PubMed ID: 35370291
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Li X; Wang Y; Li B; Ma W
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma.
Wang Y; Yang F; Shang J; He H; Yang Q
Sci Rep; 2021 Jul; 11(1):15175. PubMed ID: 34312475
[TBL] [Abstract][Full Text] [Related]
34. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
35. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
Front Genet; 2020; 11():534. PubMed ID: 32595697
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
38. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
39. A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma.
Zhu L; Wang Z; Sun Y; Giamas G; Stebbing J; Yu Z; Peng L
Front Oncol; 2021; 11():778637. PubMed ID: 35004299
[TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
